title: Infrainguinal arterial reconstruction in end-stage renal disease.
abstract: A total of 14 infrainguinal revascularizations in 11 patients with end-stage renal disease resulting from diabetes mellitus were reviewed. Indications for surgery comprised gangrene or non-healing ulcerations in eight patients (11 limbs), ischaemic rest pain in two (two limbs) and disabling claudication in one (one limb). No graft failures occurred during the period of observation. There were two immediate postoperative deaths, one amputation, and four persistent non-healing foot ulcers. The remaining four patients showed improvement. Six deaths occurred, including two perioperative deaths. Four patients with non-healing ulcers died within 1 year and 10 months after revascularization, but their deaths were not associated with the foot ulcers. The cumulative patient survival rate was 42% at 1 year. Infrainguinal revascularization in patients with end-stage renal disease caused by diabetes mellitus is feasible when meticulous preoperative assessment and careful perioperative management are employed to minimize operative risk.
authors.affiliation: First Department of Surgery, Nagoya University School of Medicine, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Sakurai
authors.forename: M
authors.initials: M
authors.lastname: Kobayashi
authors.forename: H
authors.initials: H
authors.lastname: Harasawa
authors.forename: A
authors.initials: A
authors.lastname: Itoh
authors.forename: C
authors.initials: C
authors.lastname: Yamazaki
authors.forename: K
authors.initials: K
authors.lastname: Masuko
mesh_terms: D000368:Aged; D001158:Arteries / Q000601:surgery; D001807:Blood Vessel Prosthesis / Q000401:mortality; D003928:Diabetic Nephropathies / Q000150:complications*; D005260:Female; D006801:Humans; D007511:Ischemia / Q000601:surgery*; D007676:Kidney Failure, Chronic / Q000150:complications*; D007866:Leg / Q000098:blood supply*; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis; D012189:Retrospective Studies; D015996:Survival Rate; D016896:Treatment Outcome